Zhenyu Yang Ph.D.
Zhenyu Yang focuses on patent litigation, primarily in the areas of biotechnology, pharmaceuticals, and medical devices. Dr. Yang also has experience in patent prosecution, patentability assessments,
freedom-to-operate analyses, invalidity and non-infringement opinions, and due diligence.
Prior to practicing law, Dr. Yang performed research at Novartis Pharmaceuticals Corporation and a biotechnology company. While attending law school, Dr. Yang worked full-time as a patent manager at a global Fortune 100 company.
Dr. Yang frequently teaches in China on topics related to U.S. patent law.
- Eli Lilly & Co. v. Actavis Elizabeth, LLC (D.N.J.). Represented Eli Lilly against several generic companies in Abbreviated New Drug Application (ANDA) litigation pertaining to Strattera®, Eli Lilly's prescription medicine for the treatment of attention-deficit/hyperactivity disorder.
- Defended a technology company against trade secret misappropriation assertions.
- Served as a law clerk to the Honorable Paul R. Michel, U.S. Court of Appeals for the Federal Circuit, 2008-2009.
- Worked as an associate in the intellectual property group in the Washington, D.C. office at a top-tier national law firm, 2007-2008.
- Served as a program professor for the School of Public Affairs, University of Science and Technology of China, 2010.